Odevixibat: an investigational inhibitor of the ileal bile acid transporter (IBAT) for the treatment of biliary atresia

Laue, T; Baumann, U

Laue, T (通讯作者),Hannover Med Sch, Dept Paediat Liver Kidney & Metab Dis, Div Paediat Gastroenterol & Hepatol, Hannover, Germany.

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022; 31 (11): 1143

Abstract

IntroductionBiliary atresia (BA) is a rare, non-curable cholestasis-causing disease in infancy, due to progressive ascending bile duct sclerosis. Even......

Full Text Link